scholarly journals HBPF: a Home Blood Pressure Framework with SLA guarantees to follow up hypertensive patients

2016 ◽  
Author(s):  
Josep Cuadrado ◽  
Jordi Vilaplana ◽  
Jordi Mateo ◽  
Francesc Solsona ◽  
Sara Solsona ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Virtual Machines ◽  
The Elderly ◽  
Home Blood Pressure ◽  
Mobile App ◽  
Hypertensive Patients ◽  
Cross Platform ◽  
User Friendly ◽  
Health Care Centers

Hypertension or high blood pressure is a condition on the rise. Not only does it affect the elderly but is also increasingly spreading to younger sectors of the population. Treating it involves exhaustive monitoring of patients. A tool adapted to the particular requirements of hypertension can greatly facilitate monitoring and diagnosis. This paper presents HBPF, an efficient cloud-based Home Blood Pressure Framework. This allows hypertensive patients to communicate with their health-care centers, thus facilitating monitoring for both patients and clinicians. HBPF provides a complete, efficient, and cross-platform framework to follow up hypertensive patients with an SLA guarantee. Response time below one second for 80,000 requests and 28% increase in peak throughput going from one to 3 virtual machines were obtained. In addition, a mobile app (BP) for Android and iOS with a user-friendly interface is also provided to facilitate following up hypertensive patients. Among them, between 54% and 87% favorably evaluated the tool. BP can be downloaded for free from the website Hesoft Group repository (http://www.hesoftgroup.eu).

scholarly journals HBPF: a Home Blood Pressure Framework with SLA guarantees to follow up hypertensive patients

2016 ◽  
Vol 2 ◽  
pp. e69
Author(s):  
Josep Cuadrado ◽  
Jordi Vilaplana ◽  
Jordi Mateo ◽  
Francesc Solsona ◽  
Sara Solsona ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Virtual Machines ◽  
The Elderly ◽  
Home Blood Pressure ◽  
Mobile App ◽  
Hypertensive Patients ◽  
Cross Platform ◽  
User Friendly ◽  
Health Care Centers

Hypertension or high blood pressure is a condition on the rise. Not only does it affect the elderly but is also increasingly spreading to younger sectors of the population. Treating it involves exhaustive monitoring of patients. A tool adapted to the particular requirements of hypertension can greatly facilitate monitoring and diagnosis. This paper presents HBPF, an efficient cloud-based Home Blood Pressure Framework. This allows hypertensive patients to communicate with their health-care centers, thus facilitating monitoring for both patients and clinicians. HBPF provides a complete, efficient, and cross-platform framework to follow up hypertensive patients with an SLA guarantee. Response time below one second for 80,000 requests and 28% increase in peak throughput going from one to three virtual machines were obtained. In addition, a mobile app (BP) for Android and iOS with a user-friendly interface is also provided to facilitate following up hypertensive patients. Among them, between 54% and 87% favorably evaluated the tool. BP can be downloaded for free from the website Hesoft Group repository (http://www.hesoftgroup.eu).

scholarly journals HBPF: a Home Blood Pressure Framework with SLA guarantees to follow up hypertensive patients

2016 ◽  
Author(s):  
Josep Cuadrado ◽  
Jordi Vilaplana ◽  
Jordi Mateo ◽  
Francesc Solsona ◽  
Sara Solsona ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Virtual Machines ◽  
The Elderly ◽  
Home Blood Pressure ◽  
Mobile App ◽  
Hypertensive Patients ◽  
Cross Platform ◽  
User Friendly ◽  
Health Care Centers

Hypertension or high blood pressure is a condition on the rise. Not only does it affect the elderly but is also increasingly spreading to younger sectors of the population. Treating it involves exhaustive monitoring of patients. A tool adapted to the particular requirements of hypertension can greatly facilitate monitoring and diagnosis. This paper presents HBPF, an efficient cloud-based Home Blood Pressure Framework. This allows hypertensive patients to communicate with their health-care centers, thus facilitating monitoring for both patients and clinicians. HBPF provides a complete, efficient, and cross-platform framework to follow up hypertensive patients with an SLA guarantee. Response time below one second for 80,000 requests and 28% increase in peak throughput going from one to 3 virtual machines were obtained. In addition, a mobile app (BP) for Android and iOS with a user-friendly interface is also provided to facilitate following up hypertensive patients. Among them, between 54% and 87% favorably evaluated the tool. BP can be downloaded for free from the website Hesoft Group repository (http://www.hesoftgroup.eu).

scholarly journals BPcontrol

2016 ◽  
Vol 07 (04) ◽  
pp. 1120-1134 ◽  
Author(s):  
Adrián Carrera ◽  
Marc Pifarré ◽  
Jordi Vilaplana ◽  
Josep Cuadrado ◽  
Sara Solsona ◽  
...  
Keyword(s):  
Operating Systems ◽  
The Elderly ◽  
Mobile App ◽  
Hypertensive Patients ◽  
Monitoring And Diagnosis ◽  
Start Up ◽  
Communication Efficiency ◽  
Efficiency Factors ◽  
User Friendly ◽  
Health Care Centers

SummaryBackground Hypertension or high blood pressure is on the rise. Not only does it affect the elderly but is also increasingly spreading to younger sectors of the population. Treating this condition involves exhaustive monitoring of patients. The current mobile health services can be improved to perform this task more effectively.Objective To develop a useful, user-friendly, robust and efficient app, to monitor hypertensive patients and adapted to the particular requirements of hypertension.Methods This work presents BPcontrol, an Android and iOS app that allows hypertensive patients to communicate with their health-care centers, thus facilitating monitoring and diagnosis. Usability, robustness and efficiency factors for BPcontrol were evaluated for different devices and operating systems (Android, iOS and system-aware). Furthermore, its features were compared with other similar apps in the literature.Results BPcontrol is robust and user-friendly. The respective start-up efficiency of the Android and iOS versions of BPcontrol were 2.4 and 8.8 times faster than a system-aware app. Similar values were obtained for the communication efficiency (7.25 and 11.75 times faster for the Android and iOS respectively). When comparing plotting performance, BPcontrol was on average 2.25 times faster in the Android case. Most of the apps in the literature have no communication with a server, thus making it impossible to compare their performance with BPcontrol.Conclusions Its optimal design and the good behavior of its facilities make BPcontrol a very promising mobile app for monitoring hypertensive patients.Citation: Carrera A, Pifarré M, Vilaplana J, Cuadrado J, Solsona S, Mateo J, Solsona F. BPcontrol: a mobile app to monitor hypertensive patients

scholarly journals Correction: HBPF: a Home Blood Pressure Framework with SLA guarantees to follow up hypertensive patients

2017 ◽  
Vol 2 ◽  
pp. ecs-cs-69/correction-1
Author(s):  
Josep Cuadrado ◽  
Jordi Vilaplana ◽  
Jordi Mateo ◽  
Francesc Solsona ◽  
Sara Solsona ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Home Blood Pressure ◽  
Hypertensive Patients

Predictive power of home blood pressure indices at baseline and during follow-up in hypertensive patients: HOMED-BP study

2018 ◽  
Vol 41 (8) ◽  
pp. 622-628 ◽  
Author(s):  
Daisuke Watabe ◽  
◽  
Kei Asayama ◽  
Tomohiro Hanazawa ◽  
Miki Hosaka ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Predictive Power ◽  
Home Blood Pressure ◽  
Hypertensive Patients

scholarly journals Improving the Blood Pressure Control With the ProActive Attitude of Hypertensive Patients Seeking Follow-up Services

Medicine ◽  
2016 ◽  
Vol 95 (14) ◽  
pp. e3233 ◽  
Author(s):  
Shangfeng Tang ◽  
Ghose Bishwajit ◽  
Lu Ji ◽  
Da Feng ◽  
Haiqing Fang ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Blood Pressure Control ◽  
Pressure Control ◽  
Hypertensive Patients

Abstract P494: Long-term Outcomes of a Cluster-randomized Trial Testing the Effects Blood Pressure Telemonitoring and Pharmacist Management

Hypertension ◽  
2017 ◽  
Vol 70 (suppl_1) ◽  
Author(s):  
Karen L Margolis ◽  
Stephen E Asche ◽  
Anna R Bergdall ◽  
Steven P Dehmer ◽  
Beverly B Green ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Randomized Trial ◽  
Clinical Care ◽  
Cluster Randomized Trial ◽  
Home Blood Pressure ◽  
Uncontrolled Hypertension ◽  
Routine Clinical Care ◽  
Differential Reduction ◽  
Cluster Randomized

Background/Aims: Hypertension is a common condition and leading cause of cardiovascular disease. We previously reported results of a cluster-randomized trial evaluating a home blood pressure (BP) telemonitoring and pharmacist management intervention, with significant reductions in BP favoring the intervention arm over 18 months. This analysis examined the durability of the intervention effect on BP through 54 months of follow-up and compared BP measurements performed in the research clinic and in routine clinical care. Methods: The Hyperlink trial randomized 16 primary care clinics having 450 study-enrolled patients with uncontrolled hypertension to either Telemonitoring Intervention (TI) or usual care (UC) study arms. BP was measured as the mean of 3 measurements obtained at each research clinic visit. General linear mixed models utilizing a direct likelihood-based ignorable approach for missing data were used to examine change from baseline to 54 months in systolic and diastolic BP (SBP and DBP). Results: Research clinic BP measurements were obtained from 326 (72%) study patients at the 54 month follow-up visit. Routine clinical care BP measurements were obtained from 444 (99%) of study patients from 7025 visits during the follow-up period. For TI patients, based on research clinic measurements baseline SBP was 148.2 mm Hg and 54 month follow-up was 131.2 mm Hg (-17.0 mm Hg, p<.001). For UC patients, baseline SBP was 147.7 mm Hg and 54 month follow-up was 131.7 mm Hg ( -16.0 mm Hg, p<.001). The differential reduction by study arm in SBP from baseline to 54 months was -1.0 mm Hg (95% CI: -5.4 to 3.4, p=0.63). For TI patients, baseline DBP was 84.4 mm Hg and 54 month follow-up was 77.8 (-6.6 mm Hg, p<.001). For UC patients, baseline DBP was 85.1 mm Hg and 54 month follow-up was 79.1 mm Hg (-6.0 mm Hg, p<.001). The differential reduction by study arm in DBP from baseline to 54 months was -0.6 mm Hg (95% CI: -3.5 to 2.4, p=0.67). SBP and DBP results from routine clinical measurements closely approximated the pattern of results from research clinic measurements. Conclusion: Significant BP reductions in the TI arm relative to UC were no longer seen at 54 month follow-up. To maintain intervention benefits over a longer period of time additional intervention is needed.

Sign in / Sign up

Export Citation Format

Share Document